NEWS

Stay informed about the latest NEWS from SOCIUM.

2025-07-31	SOCIUM Inc. Signs Strategic Alliance Agreement with LTT Bio-Pharma Co.Ltd.
2025-07-29	ソシウム株式会社 株式投資型クラウドファンディング実施 及び オンライン事業説明会開催のお知らせ
2025-07-22	SOCIUM Inc. signs an agreement with Suzhou Brainlight Biomedical Technology Co., Ltd
2025-07-07	A research paper by joint research with Nanjing Medical University has been published in an international academic journal
2025-05-20	SOCIUM Inc. and Nanjing Medical University File Joint Patent in China
2025-04-21	Results of Joint Research on Drug Development with Nanjing Medical University Published in a Leading International Journal
2025-04-15	The application of a drug candidate for ALS treatment was issued as a patent
2025-02-12	A paper on our phosphorylation analysis service was published in a leading international academic journal
2024-12-23	Our Phosphorylation Analysis Service to Expand in the U.S.
2024-09-17	SOCIUM Inc. and Huaxi Hospital of Sichuan University have decided to conduct an investigator-initiated clinical trial of SO-002, a drug candidate for the treatment of amyotrophic lateral sclerosis (ALS)